Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
11.62
+0.72 (6.61%)
Nov 13, 2026, 4:00 PM EST - Market closed
Fennec Pharmaceuticals Employees
Fennec Pharmaceuticals had 35 employees as of December 31, 2025. The number of employees increased by 3 or 9.38% compared to the previous year. That makes Fennec Pharmaceuticals the 36,592nd largest employer in the world and 5,021st in the United States.
Employees
35
Change (1Y)
3
Growth (1Y)
9.38%
Revenue / Employee
$1,896,200
Profits / Employee
$57,914
Market Cap
410.25M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 35 | 3 | 9.38% |
| Dec 31, 2024 | 32 | 3 | 10.34% |
| Dec 31, 2023 | 29 | -7 | -19.44% |
| Dec 31, 2022 | 36 | 26 | 260.00% |
| Dec 31, 2021 | 10 | 1 | 11.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ARS Pharmaceuticals | 206 |
| CorMedix | 191 |
| Puma Biotechnology | 179 |
| MapLight Therapeutics | 133 |
| Assembly Biosciences | 73 |
| Prothena Corporation | 67 |
| Rezolute | 63 |
| Tectonic Therapeutic | 60 |
FENC News
- 3 days ago - Fennec Pharmaceuticals Earnings Call Transcript: Q3 2026 - Transcripts
- 3 days ago - Fennec Pharmaceuticals Earnings release: Q3 2026 - Filings
- 3 days ago - Fennec Pharmaceuticals Quarterly report: Q3 2026 - Filings
- 3 days ago - Fennec Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 9 days ago - Fennec Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 12, 2026 - GlobeNewsWire
- 1 month ago - Fennec presents results from STS-J01 clinical trial evaluating Pedmark - TheFly
- 1 month ago - Fennec Pharmaceuticals Announces Oral Presentation of Detailed Results from Investigator-Initiated Phase 2 STS-J01 Clinical Study of Pedmark® in Japan at SIOP 2026 - GlobeNewsWire
- 2 months ago - Fennec Pharmaceuticals Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts